|13.75||+0.3200||+2.38%||Vol 16.97K||1Y Perf 130.37%|
|Apr 23rd, 2021 10:18 DELAYED|
|- -%||- -|
|Target Price||12.33||Analyst Rating||Hold 2.67|
|Potential %||-10.46||Finscreener Ranking||★★+ 49.14|
|Insiders Trans % 3/6/12 mo.||-/-/100||Value Ranking||★★★ 51.98|
|Insiders Value % 3/6/12 mo.||-/-/100||Growth Ranking||★+ 41.01|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/100||Income Ranking||— -|
|Market Cap||515.80M||Earnings Rating||Strong Buy|
|Price Range Ratio 52W %||98.40||Earnings Date||5th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||5th May 2021|
|Estimated EPS Next Report||0.34|
|EPS Growth Next 5 Years %||8.70|
|Avg. Weekly Volume||167.76K|
|Avg. Monthly Volume||204.67K|
|Avg. Quarterly Volume||240.32K|
Cross Country Healthcare Inc. (NASDAQ: CCRN) stock closed at 13.43 per share at the end of the most recent trading day (a 3.47% change compared to the prior day closing price) with a volume of 283.60K shares and market capitalization of 515.80M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Business Services industry, Industrials sector and employs 1700 people. Cross Country Healthcare Inc. CEO is Kevin Clark.
The one-year performance of Cross Country Healthcare Inc. stock is 130.37%, while year-to-date (YTD) performance is 51.41%. CCRN stock has a five-year performance of 3.63%. Its 52-week range is between 4.5 and 13.9, which gives CCRN stock a 52-week price range ratio of 98.40%
Cross Country Healthcare Inc. currently has a PE ratio of -36.40, a price-to-book (PB) ratio of 3.19, a price-to-sale (PS) ratio of 0.76, a price to cashflow ratio of 17.40, a PEG ratio of 2.32, a ROA of -3.35%, a ROC of -6.40% and a ROE of -7.82%. The company’s profit margin is -1.69%, its EBITDA margin is 0.40%, and its revenue ttm is $626.35 Million , which makes it $16.70 revenue per share.
Of the last four earnings reports from Cross Country Healthcare Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.34 for the next earnings report. Cross Country Healthcare Inc.’s next earnings report date is 05th May 2021.
The consensus rating of Wall Street analysts for Cross Country Healthcare Inc. is Hold (2.67), with a target price of $12.33, which is -10.46% compared to the current price. The earnings rating for Cross Country Healthcare Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Cross Country Healthcare Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Cross Country Healthcare Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 28.24, ATR14 : 0.60, CCI20 : 214.86, Chaikin Money Flow : 0.04, MACD : 0.83, Money Flow Index : 64.27, ROC : 8.22, RSI : 71.07, STOCH (14,3) : 72.35, STOCH RSI : 0.71, UO : 58.49, Williams %R : -27.65), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Cross Country Healthcare Inc. in the last 12-months were: Buffy S White (Buy at a value of $4 493), Darrell S. Freeman (Buy at a value of $103 000), Joseph A. Trunfio (Buy at a value of $198 400), Kevin Clark (Buy at a value of $283 957), Stephen A. Saville (Buy at a value of $11 480), Susan E. Ball (Buy at a value of $24 768), Thomas C. Dircks (Buy at a value of $100 050), W. Larry Cash (Buy at a value of $139 540), William Burns (Buy at a value of $14 070)
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.